Total Valuation
BioAdaptives has a market cap or net worth of $14.63K. The enterprise value is $418.80K.
Market Cap$14.63K
Enterprise Value$418.80K
Share Statistics
BioAdaptives has 12,008,659 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,008,659
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioAdaptives’s return on equity (ROE) is 0.73 and return on invested capital (ROIC) is 59.70%.
Return on Equity (ROE)0.73
Return on Assets (ROA)-6.90
Return on Invested Capital (ROIC)59.70%
Return on Capital Employed (ROCE)0.49
Revenue Per Employee18.28K
Profits Per Employee-1.56M
Employee Count1
Asset Turnover0.08
Inventory Turnover0.13
Valuation Ratios
The current PE Ratio of BioAdaptives is ―. BioAdaptives’s PEG ratio is -0.00405.
PE Ratio―
PS Ratio12.18
PB Ratio-0.10
Price to Fair Value-0.10
Price to FCF-0.42
Price to Operating Cash Flow-0.03
PEG Ratio-0.00405
Income Statement
In the last 12 months, BioAdaptives had revenue of 18.28K and earned -1.56M in profits. Earnings per share was -0.15.
Revenue18.28K
Gross Profit12.50K
Operating Income-1.04M
Pretax Income-1.56M
Net Income-1.56M
EBITDA-1.03M
Earnings Per Share (EPS)-0.15
Cash Flow
In the last 12 months, operating cash flow was -502.96K and capital expenditures -18.00K, giving a free cash flow of -520.96K billion.
Operating Cash Flow-502.96K
Free Cash Flow-520.96K
Free Cash Flow per Share-0.04
Dividends & Yields
BioAdaptives pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.02
52-Week Price Change-50.00%
50-Day Moving Average0.01
200-Day Moving Average0.02
Relative Strength Index (RSI)43.40
Average Volume (3m)142.01K
Important Dates
BioAdaptives upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
BioAdaptives as a current ratio of 0.09, with Debt / Equity ratio of -21.36%
Current Ratio0.09
Quick Ratio0.07
Debt to Market Cap1.73
Net Debt to EBITDA-0.22
Interest Coverage Ratio-14.70
Taxes
In the past 12 months, BioAdaptives has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioAdaptives EV to EBITDA ratio is -0.43, with an EV/FCF ratio of -0.84.
EV to Sales24.54
EV to EBITDA-0.43
EV to Free Cash Flow-0.84
EV to Operating Cash Flow-0.87
Balance Sheet
BioAdaptives has $73.61K in cash and marketable securities with $456.31K in debt, giving a net cash position of -$382.70K billion.
Cash & Marketable Securities$73.61K
Total Debt$456.31K
Net Cash-$382.70K
Net Cash Per Share-$0.03
Tangible Book Value Per Share-$0.21
Margins
Gross margin is 66.66%, with operating margin of -5701.79%, and net profit margin of -8523.35%.
Gross Margin66.66%
Operating Margin-5701.79%
Pretax Margin-8523.35%
Net Profit Margin-8523.35%
EBITDA Margin-5658.02%
EBIT Margin-8135.56%
Analyst Forecast
The average price target for BioAdaptives is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3424.74%
EPS Growth Forecast-63.43%